Stock Market Reviews

Read and share opinions on CGC (Canopy Growth Corporation) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights
  Dec 30, 2025
• Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  Dec 22, 2025
• Micron soars, cannabis stocks pop on Trump's executive order
  Dec 18, 2025
• Canopy Growth Is Surging and Analysts Still Think It Can Gain 40% from Here
  Dec 17, 2025

CGC News

• Do These 2 Cannabis Stocks Have a Future?
  Don't get your hopes up.
  Dec 29, 2025
• Canopy Growth (TSX:WEED): Repricing Its Valuation After Historic U.S. Cannabis Reclassification and Turnaround Moves
  U.S. President Donald Trump’s move to reclassify cannabis to Schedule III has been a genuine line in the sand for the sector, and Canopy Growth (TSX:WEED) is suddenly back on many watchlists. See our latest analysis for Canopy Growth. The stock has swung sharply around the news, with a roughly 30.8 percent 1 month share price return but a steep year to date share price decline and a 5 year total shareholder return of about negative 99 percent. Momentum is rebuilding from a very low base as...
  Dec 22, 2025
• Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  In the most recent trading session, Canopy Growth Corporation (CGC) closed at $1.32, indicating a -10.81% shift from the previous trading day.
  Dec 22, 2025
• President Donald Trump Just Fast-Tracked the Rescheduling of Marijuana, and Pot Stocks Plunged -- Here's the Nefarious Reason Why
  Trump's historic executive order to reclassify cannabis isn't the victory it appears to be.
  Dec 22, 2025
• Down 99% in 5 Years, Is It Finally Time to Buy This Stock?
  Is it a cheap stock or a value trap?
  Dec 19, 2025
• Tax Breaks Are the Biggest Win for Marijuana Businesses as Restrictions Ease
  Pot stocks fell for the second day Friday, but traders may be underestimating cost savings from Trump’s move to reclassify cannabis products.
  Dec 19, 2025
• Cannabusiness Prospects Light Up as White House Reclassifies Marijuana
  President Trump's executive order changing the classification of marijuana could lower taxes for some businesses and prompt new research.
  Dec 19, 2025
• Trump’s Marijuana Order Isn’t Helping Cannabis Stocks
  Cannabis stocks remain under pressure after President Donald Trump signed an executive order Thursday directing the Department of Justice to reschedule marijuana as a lower-class drug. The Department of Justice’s proposed rule, first issued in May 2024, will reclassify marijuana as a Schedule III drug from Schedule I but doesn’t permit legalized recreational sales. Other Schedule I substances include highly addictive drugs with no accepted medical use, such as heroin, while Schedule III substances are considered to have lower potential for abuse.
  Dec 19, 2025
• BC-Most Active Stocks
  Nu Holdings Ltd. 39,065,865 16.3555
  Dec 18, 2025
• Micron soars, cannabis stocks pop on Trump's executive order
  Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Micron Technology (MU) stock soaring due to high demand on its high-bandwidth memory chips and cannabis stocks Canopy Growth (CGC) and Tilray Brands (TLRY) rising after President Trump signed an executive order to expedite the reclassification of marijuana to a Schedule III drug. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
  Dec 18, 2025
• Cloud lifts over cannabis companies' future amid push to reclassify the drug
  Cannabis companies like Tilray Brands and Canopy Growth could soon face a more mellow path ahead following President Donald Trump's move to help reclassify the drug's status. The companies had a mostly muted reaction to Trump's executive order, though the sector has been gaining ground since last week in anticipation of the move. Trump's executive order would speed up the Drug Enforcement Administration's process that would shift the drug's current classification as a Schedule I drug, alongside heroin and LSD.
  Dec 18, 2025
• Trump signs EO to reschedule marijuana, but a few hurdles remain
  President Trump has signed an executive order to expedite the rescheduling of marijuana from a Schedule I drug to a less-severe Schedule III drug. Yahoo Finance Senior Producer John Hyland joins Market Domination Overtime host Josh Lipton to explain what we know. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.
  Dec 18, 2025
• Wall Street Rebounds Following Cooler-Than-Expected Consumer Inflation
  The S&P 500 and the Dow Jones Industrial Average snapped a four-day slump on Thursday after data sho
  Dec 18, 2025
• Trump Signs Marijuana Reclassification Order, Paving Way For Medical Research
  US President Donald Trump on Thursday signed an executive order to ease restrictions on marijuana in
  Dec 18, 2025
• Tilray and Cannabis Stocks Fall as Trump Reschedules Marijuana
  Cannabis stocks fell Thursday after President Donald Trump signed an executive order to reschedule marijuana as a lower-class drug. Trump’s order reclassifies marijuana as a Schedule III drug from Schedule I, but doesn’t permit legalized recreational sales. Other Schedule I substances include highly addictive drugs with no accepted medical use, such as heroin, while Schedule III substances are considered to have lower potential for abuse.
  Dec 18, 2025
• Stock Market Today, Dec. 18: Tilray Brands Jumps After Trump Order Spurs Cannabis Rescheduling
  Today, Dec. 18, 2025, investors are weighing Tilray’s fresh U.S. medical push and sector volatility after federal cannabis rescheduling.
  Dec 18, 2025
• BC-Most Active Stocks
  Nu Holdings Ltd. 53,855,049 16.16
  Dec 17, 2025
• Trump Reignites Marijuana Stock Rally With Reclassification Executive Order Expected Thursday
  Trump kicked off a marijuana stock rally last week and it picked up steam Wednesday with an executive order expected Thursday.
  Dec 17, 2025
• Canopy Growth Is Surging and Analysts Still Think It Can Gain 40% from Here
  Canopy Growth soars on reports the White House is considering reclassifying cannabis as a “Schedule III” drug. Here’s why CGC shares currently look attractive as a long-term holding.
  Dec 17, 2025
• BC-Most Active Stocks
  Nu Holdings Ltd. 45,437,057 16.52
  Dec 16, 2025
• Explainer-How US marijuana reclassification could help cannabis companies
  Dec 15 (Reuters) - U.S. President Donald Trump said he is considering signing an executive order to reclassify marijuana as a less dangerous drug, though he offered no timeline for the move.
  Dec 16, 2025
• Trump’s Giving Cannabis Stocks a Lift—and the Optimism May Be Justified
  After many false starts, investors are once again betting that marijuana businesses are close to seeing federal restrictions ease.
  Dec 16, 2025
• Stock Market Today, Dec. 16: Tilray Brands Surges 27.5% After Trump Signals Possible Marijuana Reclassification
  Tilray’s jump in a broad cannabis rally shows how shifting U.S. policy signals are jolting traders, today, Dec. 16, 2025.
  Dec 16, 2025
• BC-Most Active Stocks
  HIVE Digital Technologies Ltd. 15,017,784 3.07
  Dec 15, 2025
• Canopy Growth Up Near 7% In US Premarket As Moves To Acquire MTL Cannabis
  Canopy Growth Corporation (WEED.TO and Nasdaq: CGC) was at last look up near 7% in US premarket trad
  Dec 15, 2025
• Why Canopy Growth (TSX:WEED) Is Up 57.9% After New Product Launches And U.S. Rescheduling Buzz
  Earlier this month, Canopy Growth announced the Canada-wide launch of Claybourne Gassers liquid diamond AIO vapes and Frosted Flyers infused pre-roll variety packs, targeting both recreational and medical consumers through licensed retailers and its Spectrum Therapeutics online store. At the same time, reports that President Trump plans to reschedule marijuana as a Schedule III drug are reshaping expectations for how cannabis producers such as Canopy Growth might access U.S. banking, tax...
  Dec 15, 2025
• Tilray CEO says THC drink regulation will benefit cannabis companies
  President Trump is expected to sign an executive order that could reclassify marijuana from a Schedule I to a Schedule III drug, which would enable cannabis to be federally classified for medical use. Tilray Brands (TLRY) Chairman and CEO Irwin Simon sits down with Julie Hyman to share his outlook on his company's THC and hemp products in relation to Congress' latest budget bill that could see a ban on most hemp-derived THC products by late 2026. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.
  Dec 15, 2025
• Cannabis stocks pull back, IMAX upgraded to Overweight
  Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including cannabis stocks like Tilray Brands (TLRY) and Canopy (CGC) pulling back ahead of expectations for President Trump to sign an executive order reclassifying marijuana to a Schedule III drug, and JPMorgan analysts upgrading IMAX (IMAX) shares to an Overweight rating. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
  Dec 15, 2025
• Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand
  SMITHS FALLS, Ontario & POINTE-CLAIRE, Quebec, December 15, 2025--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) and MTL Cannabis Corp. ("MTL Cannabis" or "MTL") (CSE: MTLC) (OTCQX: MTLNF) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") pursuant to which Canopy Growth will acquire all of the issued and outstanding common shares of MTL (the "MTL Shares") and will settle all debt and debt-l
  Dec 15, 2025
• Tilray Brands Soars on Reports of Likely US Marijuana Reclassification
  TLRY surges 44.1% on reports that Trump may reclassify marijuana, sparking hopes for eased federal rules and renewed investor enthusiasm.
  Dec 15, 2025
• Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights
  Canopy Growth Corporation (CGC) concluded the recent trading session at $1.66, signifying a -4.6% move from its prior day's close.
  Dec 15, 2025
• Cannabis Stocks Drop. Will Trump Reclassify Marijuana Today?
  Marijuana stocks surged Friday after reports that Trump could sign an executive order reclassifying cannabis.
  Dec 15, 2025
• Trending tickers: Tesla, iRobot, Canopy Growth, STMicroelectronics and HSBC
  The latest investor updates on stocks that are trending on Monday
  Dec 15, 2025
• The Rally for Cannabis Stocks Grinds to a Halt Amid Uncertainty About Trump Order
  Weed stocks dropped Monday, reversing early gains on hopes President Trump could soon issue an executive order reclassifying marijuana.
  Dec 15, 2025
• Want to Jump on the Cannabis Stocks Rally? This Company Has Been the Top-Performing Player in 2025.
  Down almost 70% from all-time highs, Curaleaf stock offers significant upside potential given its widening free cash flow margins.
  Dec 15, 2025
• India Ups Its Textile-to-Textile Recycling Game as Re-Start launches a 13 Million Euro Flagship Project
  The initiative will focus on select geographies, or clusters, with the first program being rolled out in Ludhiana and Indore.
  Dec 15, 2025
• Trump expected to sign EO to reclassify marijuana as soon as Monday, CNBC says
  Cannabis stocks jumped on Friday following reports that President Donald Trump will significantly ease federal restrictions on marijuana, with an executive order seen as coming as soon as Monday, CNBC’s Alex Harring and Brandon Gomez report. Trump is expected to use an executive order to instruct federal agencies to reclassify marijuana as a less regulated Schedule III drug from a Schedule I, the Washington Post reported on Thursday. Such a move would allow cannabis companies to fall under diffe
  Dec 13, 2025
• BC-Most Active Stocks
  Nu Holdings Ltd. 36,506,840 17.06
  Dec 12, 2025
• S&P 500, Dow Retreat From Record Amid Broadcom-Led Tech Selloff
  The S&P 500 and the Dow Jones Industrial Average retreated from record highs as margin concerns faci
  Dec 12, 2025
• TSX Down 250 Points With Info Tech, Miners, The Worst Performers, Cannabis Stocks Surge
  The Toronto Stock Exchange was down 250 points midday on Friday with tech, down 4%, and miners, down
  Dec 12, 2025
• Why Canopy Growth Stock Popped Today
  President Trump wants to change the regulations on cannabis. Will this change Canopy into a profitable stock?
  Dec 12, 2025
• Cannabis stocks climb as Trump weighs marijuana rescheduling
  Investing.com -- Cannabis stocks surged Friday after reports that President Donald Trump is considering directing his administration to reclassify marijuana as a less dangerous drug, potentially marking a significant shift in U.S. policy.
  Dec 12, 2025
• Cannabis stocks surge on report Trump seeks to ease restrictions
  <body><p>STORY: Shares of cannabis companies soared on Friday after a report said President Donald Trump is looking to dramatically loosen federal restrictions on marijuana.</p><p>The Washington Post a day earlier reported that Trump plans to direct federal agencies to reclassify pot as a Schedule III drug.</p><p>It is currently listed as a Schedule I substance, meaning it has a high potential for abuse and no currently accepted medical use.</p><p>A shift to Schedule III would reduce oversight of the plant and its derivatives to the same level as some common prescription painkillers and other drugs.</p><p>Investors reacted quickly to the news, with U.S.-listed shares of cannibis company Tilray Brands skyrocketing more than 44%, while shares of SNDL, Canopy Growth and ETF AdvisorShares Pure US Cannabis were up between 24% and 39% in Friday morning trading.</p><p>The reclassification could also ease criminal penalties regarding marijuana, and reshape the industry through potentially lower taxes and easier means of funding.</p><p>Funding remains one of the biggest challenges for cannabis producers, as federal restrictions keep most banks and institutional investors out of the sector, forcing producers to turn to costly loans or alternative lenders.</p><p>The Drug Enforcement Administration has to review the recommendation and will decide on the reclassification.</p></body>
  Dec 12, 2025
• Cannabis Stocks Soar as Trump Reportedly Seeks to Ease Restrictions on Marijuana
  Shares of cannabis companies surged on Friday following reports that US President Donald Trump was s
  Dec 12, 2025
• Equity Markets Fall Intraday as Broadcom Weighs on Tech Sector
  US benchmark equity indexes were lower intraday as the technology sector tumbled amid a post-earning
  Dec 12, 2025
• Sector Update: Consumer Stocks Advance Friday Afternoon
  Consumer stocks rose Friday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF
  Dec 12, 2025
• Sector Update: Consumer Stocks Rise Late Afternoon
  Consumer stocks advanced late Friday afternoon, with the State Street Consumer Staples Select Sector
  Dec 12, 2025
• Trump headlines boost cannabis stocks, RH rises on Q3 earnings
  Morning Brief host Julie Hyman takes a look at some of Friday's trending tickers, including Fermi (FRMI), RH (RH), and cannabis stocks — Tilray (TLRY), Canopy (CGC), Aurora (ACB), and SNDL Inc (SNDL). To watch more expert insights and analysis on the latest market action, check out more Morning Brief.
  Dec 12, 2025
• Cannabis Stocks Surge. Trump May Reclassify Marijuana—but White House Says a Final Decision Hasn’t Been Made.
  Cannabis stocks Tilray Brands and Canopy Growth surged following reports that President Donald Trump would loosen federal restrictions on marijuana. A White House official told Barron’s that no final decision had been made regarding the rescheduling of the drug. The president indicated as far back as August that he was weighing the positives and negatives of a policy change.
  Dec 12, 2025
• Stocks to Watch Friday Recap: Broadcom, Lululemon, Tilray Brands
  ↘️ Broadcom (AVGO): Concerns about the chip maker's sales forecasts, contracts backlog and anticipated future margins overshadowed its rapid revenue growth. Shares closed 11% lower. ↗️ Lululemon (LULU): Calvin McDonald will step down in January as CEO of the athletic gear maker, which has been under pressure from its founder to make changes to reverse its “loss of cool.
  Dec 12, 2025
• Trump Lights Up the Cannabis Market With Plans for Reclassification
  The U.S. marijuana industry has stagnated for year, languishing under federal inaction on reclassification or decriminalization. Classified as a Schedule I drug under the Controlled Substances Act — alongside hard drugs like heroin and LSD — cannabis is deemed to have no accepted medical use and high abuse potential. This status blocks research, interstate commerce, ... Trump Lights Up the Cannabis Market With Plans for Reclassification
  Dec 12, 2025
• Marijuana Stocks Are Soaring Friday on Anticipation Trump Could Soon Make This Change
  Cannabis stocks surged Friday following reports President Donald Trump could soon reclassify marijuana as a less dangerous substance.
  Dec 12, 2025
• Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
  Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.
  Dec 11, 2025
• Oral Presentation at ASH 2025 Shows Canopy RTM Cuts Infection-Related Hospitalizations by 52% and Generates Nearly $1M in Annual Savings per 1,000 Patients
  Canopy, the leader in Enterprise AI for oncology, today announced new findings that highlight how its RTM Platform strengthens outpatient care and reduces infection-related escalations in patients with hematological malignancies.
  Dec 9, 2025
• Canopy Partners with Alto IRA to Streamline IRA Investing in Private Deals
  NASHVILLE, Tenn., December 09, 2025--Alto, the leading self-directed IRA platform bringing private markets to individual retirement portfolios, today announced a new partnership with Canopy, an SPV management solution empowering fund managers and investors to seamlessly close and manage private transactions. The collaboration makes it easier than ever for investors to use self-directed IRAs to invest in private offerings directly through Canopy, without the paperwork, delays, or manual back-and-
  Dec 9, 2025
• Canadian Gold Corp. Announces Shareholders Approve Arrangement with McEwen
  Flin Flon, Manitoba--(Newsfile Corp. - December 5, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold") is pleased to announce that at a special meeting of its shareholders (the "Meeting") held on December 5, 2025, shareholders overwhelmingly approved the special resolution authorizing the previously announced business combination with McEwen Inc. (NYSE: MUX) (TSX: MUX) ("McEwen") to be completed by way of statutory plan of arrangement (the "Arrangement") under the Business Corporations Act
  Dec 5, 2025
• Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment
  SMITHS FALLS, Ontario, December 04, 2025--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the national launch of Claybourne Gassers, a new lineup of All-in-One (AIO) vapes featuring liquid diamonds. The launch marks Claybourne’s entry into Canada’s vape category, building on its leadership in high potency infused products.
  Dec 4, 2025
• Leading Food Tech Platform MenuSano Launches Rapid Customization Program for Brands Navigating Regulatory and Clean Label Demands
  Co-Built Client Solutions and AI-Powered Search Assistance, Solving Complex Compliance Challenges Fast TORONTO, ONTARIO / ACCESS Newswire / December 1, 2025 / As food brands face demands beyond baseline FDA, USDA, and CFIA compliance,MenuSano,a leading ...
  Dec 1, 2025
• Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
  Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
  Nov 26, 2025
• Canopy Growth Corporation (CGC) Sets Sights on Australia Cannabis Market with Expanded Portfolio
  Canopy Growth Corp (NASDAQ:CGC) is one of the Canadian penny stocks to buy right now. On November 18, Canopy Growth Corp (NASDAQ:CGC) expanded its Spectrum Therapeutics portfolio in Australia by adding softgel capsules. The addition is part of the company’s push to target more medical cannabis patients in the country. The company will target patients […]
  Nov 25, 2025
• Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  Key Takeaways; Cannabis Sector Canopy Growth Broadened Australian Medical Lineup with New Spectrum Softgels Decibel Cannabis Saw Strong Revenue Growth in Q3 2025 Despite Posting Higher Losses Avicanna Announced Promising Preclinical Data for New Oral Cannabinoid Delivery Platform SNDL Announced Renewal to Buy Back Up to C$100 Million in Shares Under New Repurchase Program Key […]
  Nov 23, 2025
• Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels
  SMITHS FALLS, Ontario, November 18, 2025--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company’s medical cannabis offerings in the region.
  Nov 18, 2025
• This AI Stock Goes On 149% Run, Tests Entry As It Eyes Profitability Milestone
  This AI stock addresses the need for artificial intelligence in localized devices. It is seen hitting a key profitability milestone soon.
  Nov 14, 2025
• Canopy Growth Just Topped Earnings Estimates. Should You Buy, Sell, or Hold CGC Stock for November 2025?
  Canopy Growth’s latest results showcased stronger execution and renewed momentum across key markets. Is CGC stock finally turning the corner this November?
  Nov 13, 2025
• Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock
  Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
  Nov 12, 2025
• Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  Key Takeaways; Cannabis Sector Trulieve Cleared Major Debt as CEO Hailed Strategic Progress and Cash Strength Curaleaf Delivered Solid Q3 with Rising Cash Flow and International Momentum Canopy Growth Slashed Losses as Cannabis Sales Surged in Q2 2026 SNDL Reported Record Free Cash Flow and 50% Jump in Cannabis Operations Revenue Cronos Group Delivered Record […]
  Nov 10, 2025
• Analysts Have Lowered Expectations For Canopy Growth Corporation (TSE:WEED) After Its Latest Results
  Canopy Growth Corporation ( TSE:WEED ) shareholders are probably feeling a little disappointed, since its shares fell...
  Nov 10, 2025
• Canopy Growth Corp (CGC) Q2 2026 Earnings Call Highlights: Strong Domestic Growth Amid ...
  Canopy Growth Corp (CGC) reports significant gains in Canadian markets while addressing international supply chain issues and achieving notable cost savings.
  Nov 8, 2025
• Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet
  SMITHS FALLS, Ontario, November 07, 2025--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) today announced its financial results for the second quarter ended September 30, 2025 ("Q2 FY2026"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
  Nov 7, 2025
• Canopy Growth Corporation (CGC) Reports Q2 Loss, Misses Revenue Estimates
  Canopy Growth (CGC) delivered earnings and revenue surprises of +90.91% and -7.48%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 7, 2025
• Canopy Growth Corporation (CGC) Suffers a Larger Drop Than the General Market: Key Insights
  In the most recent trading session, Canopy Growth Corporation (CGC) closed at $1.22, indicating a -2.4% shift from the previous trading day.
  Oct 30, 2025
• Is Trending Stock Canopy Growth Corporation (CGC) a Buy Now?
  Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
  Oct 29, 2025
• Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025
  SMITHS FALLS, Ontario, October 24, 2025--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on November 7, 2025.
  Oct 24, 2025
• Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know
  In the most recent trading session, Canopy Growth Corporation (CGC) closed at $1.35, indicating a +2.27% shift from the previous trading day.
  Oct 24, 2025
• Canopy Growth Corporation (CGC) Stock Dips While Market Gains: Key Facts
  In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.31, marking a -2.96% move from the previous day.
  Oct 17, 2025
• Canopy Hot Button Report positive on supply chain transformation
  The 10th edition of the Hot Button report published by non-profit eco organisation Canopy shows considerable change in the global man-made cellulosic fibre (MMCF) supply chain since 2016.
  Oct 16, 2025
• Canopy Growth Corporation (CGC) Falls More Steeply Than Broader Market: What Investors Need to Know
  Canopy Growth Corporation (CGC) closed the most recent trading day at $1.35, moving 7.53% from the previous trading session.
  Oct 16, 2025
• Nucleus Software Appoints Industry Veteran Nilanshuk Haldar to Drive Global Partnerships and Strategic Alliances
  Nucleus Software, a global leader in digital lending and transaction banking solutions, is pleased to announce the appointment of Nilanshuk Haldar as Vice President – Global Head of Partnerships and Alliances on 3rd October 2025. In this role, Nilanshuk will spearhead the company's global partner ecosystem strategy, driving revenue growth, strategic collaborations, and market expansion.
  Oct 16, 2025
• Is Most-Watched Stock Canopy Growth Corporation (CGC) Worth Betting on Now?
  Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
  Oct 15, 2025
• Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders
  SMITHS FALLS, Ontario, October 14, 2025--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to announce today the voting results from its Annual General and Special Meeting of Shareholders convened on September 26, 2025 and adjourned to, and reconvened on, October 10, 2025 (the "Meeting").
  Oct 14, 2025
• Trump’s CBD Medicare signal sparks 36% boost in cannabis stocks — but should investors hold or brace for policy risks?
  Is it high time to invest in cannabis stock?
  Oct 13, 2025
• How Will Canopy Growth’s Medical Craft Cannabis Pivot Affect Long-Term Strategy for TSX:WEED Investors?
  Canopy Growth Corporation recently announced that its DOJA facility in Kelowna, British Columbia, has shifted exclusively to medical cannabis cultivation, producing small-batch, BC-grown craft cannabis for Spectrum Therapeutics’ medical patients, including veterans. This transition highlights Canopy Growth’s renewed commitment to the medical cannabis market in Canada, focusing on quality and dedicated supply for registered patients. We'll explore how this exclusive focus on craft medical...
  Oct 13, 2025

CGC Reviews

• QuantAssault

  Dec 30, 2025

  $CGC Investing here is like rolling a joint—some say it’s a good idea, others just can’t see the vision! 🌿

  Sell

• WallStreetWraith

  Dec 30, 2025

  $CGC Still waiting for that 'high' you promised.

  Sell

• OptionOutlaw

  Dec 30, 2025

  $CGC Sitting on a green wave, yet still can't get it right.

  Sell

• DiamondHandz

  Dec 29, 2025

  $CGC This green scene is poppin’, vibes are lit!

  Buy

• BearEater

  Dec 29, 2025

  $CGC This company remains a significant contender in the cannabis industry, with strategies aligned to adapt to regulatory changes and consumer preferences, which can enhance its market position.

  Sell

• CandleCrusher

  Dec 29, 2025

  $CGC The cannabis market is a wild ride, and this player is no exception. volatility is the name of the game! Can it navigate the challenges ahead without losing its footing? Investors are anxiously pacing!

  Sell

• BullishMyth

  Dec 29, 2025

  $CGC With cannabis trends shifting like sand, this company is scrambling to stay relevant. Can they adapt to the changing tides, or will they be left behind?

  Sell

• AlphaHawk

  Dec 29, 2025

  $CGC This one’s got the glow-up vibes, ready to roll in the green!

  Buy

• YieldWarden

  Dec 29, 2025

  $CGC The cannabis market is ever-changing, and competition is fierce! Can they stand out and weather the storms that keep coming? It's an intense ride for sure!

  Sell

• CashKiller

  Dec 28, 2025

  $CGC Trying to grow in a barren field—good luck with that.

  Sell

• LiquidityLord

  Dec 27, 2025

  $CGC This company is at the forefront of a rapidly evolving market, leveraging innovative approaches to redefine traditional boundaries. With a focus on sustainable growth and strategic partnerships, it showcases a commitment to addressing emerging consumer preferences.

  Buy

• TradeBlaze

  Dec 27, 2025

  $CGC This company is at the forefront of an expanding industry, showcasing innovative products and strategic partnerships that seem poised to redefine market standards. Recent developments suggest a strong potential for growth, capturing both consumer interest and investor attention.

  Buy

• FiscalBinary

  Dec 26, 2025

  $CGC With the cannabis market still in flux, will this player be able to secure its spot or fade into the background? The stakes are high, and so is the stress!

  Sell

• TheLongPlay

  Dec 25, 2025

  $CGC Growth potential's chillin’, but don’t get too comfy, ya know?

  Sell

• ByteBull

  Dec 25, 2025

  $CGC If you think this company is mellow, wait until you see their profits roll in – like a chill summer vibe!

  Buy

• DividendVandal

  Dec 25, 2025

  $CGC As a recognized leader in the cannabis industry, this organization is exploring new market opportunities while navigating regulatory challenges. Its commitment to research and development is indicative of its forward-thinking strategy.

  Sell

• DividendJunkie

  Dec 24, 2025

  $CGC High on hopes but low on results; what a cliché.

  Sell

• LiquidKnight

  Dec 24, 2025

  $CGC Fierce competition and regulatory shifts are sending shockwaves through this sector, leaving investors on edge. Are you ready for the wild ride ahead? Brace yourself!

  Sell

• DividendDemon

  Dec 23, 2025

  $CGC It's like the cool kid in school, always on the cutting edge but also prone to some wild rumors!

  Sell

• TickerPhantom

  Dec 23, 2025

  $CGC Although facing challenges in regulatory environments, this company remains at the forefront of the cannabis industry, with potential for growth as market conditions evolve.

  Sell

• TradePhantom

  Dec 23, 2025

  $CGC Overhyped and underfunded—classic.

  Sell

• LiquidLegend

  Dec 22, 2025

  $CGC This company’s growth is so high, I half-expect it to turn into a beanstalk and take us to the land of giant profits!

  Buy

• CashCombo

  Dec 22, 2025

  $CGC They’re growing something green over there! Just make sure it’s not your average houseplant.

  Buy

• FiscalFury

  Dec 22, 2025

  $CGC Their plant is more than just a houseplant—it's like the cool uncle who always brings snacks to the party. Just don’t leave it outside too long!

  Sell

• TheGainReaper

  Dec 21, 2025

  $CGC Just another overhyped green dream gone sour.

  Sell

• StockNova

  Dec 21, 2025

  $CGC With developments in the cannabis industry, this company is poised to navigate the complexities of this evolving market. However, external regulatory challenges may temper the excitement surrounding its performance.

  Sell

• BullishShade

  Dec 21, 2025

  $CGC In the ever-evolving cannabis industry, this company is positioned to adapt to regulatory changes and market dynamics. Its focus on product innovation and brand development trends reflects a forward-thinking approach.

  Buy

• ChartPilot

  Dec 21, 2025

  $CGC The highs and lows of this cannabis giant are staggering! It's a complex situation that has everyone on edge. Can they capitalize on the opportunity, or will they get lost in the fog of uncertainty?

  Sell

• DividendDegen

  Dec 21, 2025

  $CGC Yo, this green dream is rollin' with potential vibes, fam!

  Buy

• LiquidKnight

  Dec 21, 2025

  $CGC The cannabis industry is a whirlwind of regulatory changes and market shifts. This player’s strategy is under intense scrutiny—can it adapt quickly enough, or will it fall behind in this rapidly evolving sector?

  Sell

• CashKiller

  Dec 21, 2025

  $CGC Chasing a high that keeps coming up short.

  Sell

• GainsJester

  Dec 20, 2025

  $CGC Ridin' the green wave, but it’s a rocky road ahead.

  Sell

• DividendDegen

  Dec 20, 2025

  $CGC Smokin' the competition, but watch for the highs and lows!

  Sell

• TickerTrickster

  Dec 20, 2025

  $CGC This one’s all about the high times, but watch out for the vibes!

  Sell

• ProfitFang

  Dec 19, 2025

  $CGC Navigating the evolving landscape of the cannabis industry, this company is focusing on sustainable growth and product diversification. Its strategic initiatives may bolster its market presence and profitability.

  Sell

• LiquidLegend

  Dec 18, 2025

  $CGC This one’s like that friend who keeps talking about new hobbies—always got something growing, but it’s a bit of a wild ride!

  Sell

• BullishCraze

  Dec 17, 2025

  $CGC This company operates in a rapidly evolving industry, facing both opportunities and challenges. Its strategies in product development and market expansion will be critical as it navigates regulatory landscapes and consumer preferences.

  Sell

• ShortKingston

  Dec 17, 2025

  $CGC This one might make you feel all chill and relaxed, but will it help your wallet too?

  Sell

• ChartPilot

  Dec 17, 2025

  $CGC As regulations change and consumer preferences shift, can this company stay afloat in the cannabis industry's tumultuous waters? It's a nerve-wracking situation!

  Sell

• YOLOHold

  Dec 17, 2025

  $CGC This leaf is still chillin', but the vibe ain't what it used to be.

  Sell

• VolatilityViper

  Dec 17, 2025

  $CGC Just another overhyped dream that's going up in smoke.

  Sell

• RiskProtocol

  Dec 17, 2025

  $CGC In the rapidly shifting landscape of the cannabis industry, staying ahead requires nerves of steel. Will they climb to new heights or face the consequences of regulation? It's a wild ride!

  Sell

• BearishBoi

  Dec 16, 2025

  $CGC This company is like the cool kid in class who knows how to throw a party—everyone wants in, but watch out for those wild vibes!

  Buy

• BullishCraze

  Dec 15, 2025

  $CGC Navigating the complex regulatory landscape of its industry, this company is exploring new avenues for growth in a rapidly evolving market. Their strategic pivots could position them advantageously as consumer preferences continue to shift.

  Buy

• MarketMyth

  Dec 15, 2025

  $CGC The evolving cannabis market offers intriguing possibilities, and this company's emphasis on quality and compliance could set it apart in a crowded space, inviting potential interest.

  Buy

• MarketGlitch

  Dec 15, 2025

  $CGC Amid the ever-shifting landscape of cannabis regulation and market demand, this company feels like it's always on the edge. Will they navigate the challenges or face another setback? It's a nail-biter!

  Sell

• AlphaRogue

  Dec 15, 2025

  $CGC This stock is a wild ride, like trying to surf on a wave of green! Just hold on tight!

  Buy

• ChartPilot

  Dec 15, 2025

  $CGC The cannabis sector remains rife with uncertainty. One misstep could lead to disaster, and all eyes are glued to how this company will maneuver through the smoke and mirrors!

  Sell

• TheStockKnight

  Dec 14, 2025

  $CGC A weed dream that's gone up in smoke.

  Sell

• MarketNomad

  Dec 14, 2025

  $CGC Cannabis dreams fading faster than your last high.

  Sell

• StonkDestroyer

  Dec 14, 2025

  $CGC Just a cannabis company lost in the weeds of competition.

  Sell

• GammaGrind

  Dec 13, 2025

  $CGC Not feeling the vibe; might wanna take a pass.

  Sell

• MarginDagger

  Dec 13, 2025

  $CGC This organization continues to adapt to a rapidly changing market landscape, showcasing resilience and creativity in its product offerings. Its strategic partnerships and ongoing research and development efforts signal a forward-thinking approach.

  Buy

• TickerTyrant

  Dec 13, 2025

  $CGC Living in the past while the world moves on.

  Sell

• CashMeOutside

  Dec 13, 2025

  $CGC Rollin' in the green, lookin’ to elevate the game, no doubt!

  Buy

• CapitalRush

  Dec 13, 2025

  $CGC Beautiful higher-low formation developing.

  Buy

• HoldTheLine

  Dec 13, 2025

  $CGC Heavy bid stacks showing up.

  Buy

• TickerTakedown

  Dec 13, 2025

  $CGC They’re growing more than my collection of failed plants—props for that!

  Buy

• CodeTrader

  Dec 12, 2025

  $CGC The cannabis market is shifting, and this player must adapt quickly! Investors are losing patience while waiting for a clear direction amidst the chaos!

  Sell

• RiskRaider

  Dec 12, 2025

  $CGC High probability long setup.

  Buy

• EarningsEcho

  Dec 11, 2025

  $CGC High-quality bullish setup.

  Buy

• BullishMyth

  Dec 11, 2025

  $CGC Charts look incredibly strong.

  Buy

• OptionSpectre

  Dec 11, 2025

  $CGC Strong positive correlation to market uptrend.

  Buy

• WallStreetGrim

  Dec 11, 2025

  $CGC Chart looks extremely fragile.

  Sell

• TickerTakedown

  Dec 11, 2025

  $CGC When life gives you weed stocks, remember to keep your friends close and your investments closer!

  Sell

• TradeFrenzy

  Dec 11, 2025

  $CGC Short sellers gaining confidence.

  Sell

• VolatilityNomad

  Dec 11, 2025

  $CGC Still riding the hype train, but the tracks are looking rusty.

  Sell

• OptionOutlaw

  Dec 10, 2025

  $CGC This cannabis company is high on hype, nothing else.

  Sell

• MarginMeme

  Dec 10, 2025

  $CGC This ride's been bumpy, but it might just bounce back!

  Sell

• ProfitVandal

  Dec 10, 2025

  $CGC Another overhyped cannabis stock waiting to go up in smoke.

  Sell

• MarketNomad

  Dec 9, 2025

  $CGC This company’s growth is about as uplifting as a boulder.

  Sell

• TickerFlux

  Dec 9, 2025

  $CGC Short sellers pressing advantage.

  Sell

• TradeRebel

  Dec 8, 2025

  $CGC In the unpredictable cannabis market, this company rides highs and lows. Will it find light at the end of the tunnel, or is it just a puff of smoke?

  Sell

• AlphaWave

  Dec 8, 2025

  $CGC The cannabis industry is booming, but is this giant ready to rise above the challenges? The future looks cloudy with hints of promise!

  Sell

• VolatilityViper

  Dec 8, 2025

  $CGC Stuck in the weeds while others thrive.

  Sell

• GammaSlayer

  Dec 6, 2025

  $CGC Chasing trends but always too late to the party.

  Sell

• MarketRender

  Dec 6, 2025

  $CGC In the chaotic world of cannabis, this company is battling to stay relevant amid an oversaturated market. Can they find their niche, or will they be another casualty of tough regulations and fierce competition?

  Sell

• MissionOverlord

  Dec 6, 2025

  $CGC Growing a future, but watch out for the weeds!

  Sell

• CashMeOutside

  Dec 5, 2025

  $CGC A wild ride for the green dream, but watch those ups and downs.

  Sell

• TheRiskDealer

  Dec 4, 2025

  $CGC The market seems to be holding its breath, waiting for a breakthrough that feels perpetually out of reach. Will they rise like a phoenix, or continue to flounder in uncertainty?

  Sell

• ProfitShade

  Dec 4, 2025

  $CGC High vibes only with this one, feelin' that momentum!

  Buy

• BearMarketSurvivor

  Dec 4, 2025

  $CGC Rolling with the green scene, but watch out for the highs and lows!

  Sell

• GammaGrind

  Dec 4, 2025

  $CGC Buyers look firmly in control.

  Buy

• OptionCipher

  Dec 4, 2025

  $CGC Risk remains strongly to downside.

  Sell

• QuantAssault

  Dec 3, 2025

  $CGC This one’s like a green smoothie—healthy, refreshing, and trendy. You’ll want to sip on this stock for a while!

  Buy

• RiskWraith

  Dec 2, 2025

  $CGC With constant regulatory changes shaking the cannabis market, the pressure is mounting! Will this company adapt fast enough or be left behind in the haze of uncertainty? The stakes are high!

  Sell

• AlphaStriker

  Dec 2, 2025

  $CGC This cannabis company is more of a pipe dream than a green rush.

  Sell

• RiskWraith

  Dec 2, 2025

  $CGC The buzz around cannabis is intense, but is it sustainable? With so much competition, this feels like a gamble at best. Will it thrive or will the high fade away?

  Sell

• RiskWraith

  Dec 2, 2025

  $CGC With the cannabis market fluctuating wildly, it's hard to predict where this one is heading next. Investors are on edge, hoping for a turnaround but bracing for disappointment.

  Sell

• CashCraze

  Dec 2, 2025

  $CGC Navigating the evolving cannabis market, this organization is leveraging extensive research and product diversification. Their efforts to align with regulatory frameworks may strengthen their competitive position.

  Buy

• WallStreetBandit

  Dec 2, 2025

  $CGC Good luck finding profit in this train wreck.

  Sell

• QuantRift

  Dec 1, 2025

  $CGC Facing challenges in a volatile market, this company is working to redefine its business strategy. Adjustments in approach may be necessary to regain investor confidence.

  Sell

• PnLPhantom

  Nov 30, 2025

  $CGC Facing scrutiny and market saturation, this grower must navigate a tricky landscape. Is it equipped to turn things around, or will it continue to falter? The clock is ticking!

  Sell

• FiscalRiot

  Nov 30, 2025

  $CGC This stock is caught in a whirlwind of regulatory changes and market pressures. Every rise feels precarious, and every dip sends chills down your spine—will it bounce back or hit rock bottom?

  Sell

• BagholderPrime

  Nov 30, 2025

  $CGC This cannabis company is like the laid-back chill guy at the party—good vibes but who knows what’s really going on?

  Sell

• BagholderElite

  Nov 30, 2025

  $CGC Rolling with the high vibes, but the clouds are looking a bit dark.

  Sell

• ShortSavior

  Nov 30, 2025

  $CGC Growth? More like a slow crawl into obscurity.

  Sell

• TradeNinja

  Nov 29, 2025

  $CGC This stock’s like that friend who’s always chill—perfect for keeping the vibes flowing, just don’t let it bog you down!

  Sell

• GainMachine

  Nov 28, 2025

  $CGC This stock feels like a cat meme—adorably unpredictable but with the potential to surprise you when you least expect it!

  Sell

• CapitalCrusher

  Nov 28, 2025

  $CGC This stock is like that plant in your buddy’s dorm—growing slowly but surely, just needs the right light!

  Sell

• BullBrawler

  Nov 28, 2025

  $CGC This growth is more like a wilt; better luck next time.

  Sell

• EquityPulse

  Nov 28, 2025

  $CGC With the ever-changing regulations surrounding cannabis, can this company navigate the storm? Investors are left holding their breath as market conditions shift unpredictably!

  Sell

• DiamondHands

  Nov 27, 2025

  $CGC This stock is like your fun aunt who always has the best snacks—totally chill and a little unpredictable but super enjoyable!

  Sell

• MarketMarauder

  Nov 27, 2025

  $CGC This pot stock is still trying to prove it’s not a total flop.

  Sell

• ShortKingston

  Nov 27, 2025

  $CGC If this stock were a plant, it’d either be a lush forest or just a stubborn weed. Let's hope for the forest!

  Buy

• QuantumBroker

  Nov 27, 2025

  $CGC In the ever-shifting world of cannabis, this company is trying to find stability. Investors are anxiously awaiting news that could either lead to growth or further setbacks in an already strained market.

  Sell

• BagholderPrime

  Nov 27, 2025

  $CGC If this company were a plant, it’d be thriving in a chill garden – just watch out for the water bill!

  Sell

• GainsGoblin

  Nov 26, 2025

  $CGC In the green rush, they’re hustling for that top shelf!

  Buy

• StonkPhantom

  Nov 26, 2025

  $CGC The buzz around this stock is palpable, but the pressure is mounting. Amidst regulatory challenges and market volatility, it's hard to keep your cool! Are we witnessing a breakthrough or a breakdown?

  Sell

• CapitalVortex

  Nov 26, 2025

  $CGC The cannabis market is all over the place, and one minute it seems promising, while the next it plummets. It's a wild ride with regulatory hurdles around every corner—hold onto your hat!

  Sell

• OptionMatrix

  Nov 25, 2025

  $CGC This corporation is navigating a challenging regulatory environment while striving to establish itself in a rapidly evolving market. Its ability to innovate and adapt will be crucial in determining its long-term success amid fluctuating consumer trends.

  Sell

• VolatilityStrike

  Nov 25, 2025

  $CGC In a rapidly changing industry landscape, this cannabis company is leveraging its strategic partnerships and product innovation to capture market share, reflecting a dynamic approach to growth.

  Buy

• TheQuantEdge

  Nov 23, 2025

  $CGC Amidst regulatory shifts and market volatility, this cannabis giant faces a critical junction. Every miscalculation could lead to a dramatic fallout, so the clock is ticking!

  Sell

• FinTechFrost

  Nov 23, 2025

  $CGC Like an awkward first date – a little messy but full of surprises, and hey, it could be a wild ride!

  Sell

• VolatilityStrike

  Nov 22, 2025

  $CGC Navigating the complexities of a rapidly evolving industry, this organization is well-placed to leverage its established presence and expertise. Strategic partnerships and a focus on quality could aid in capitalizing on future market trends.

  Buy

• TradeBlitz

  Nov 22, 2025

  $CGC If plants had a social media influencer, would it be these guys? Just a bunch of green thumbs trying to grow their fanbase!

  Sell

• BullRunBoi

  Nov 22, 2025

  $CGC Chillin' in the green scene, but that market be shady sometimes.

  Sell

• BullishBard

  Nov 21, 2025

  $CGC It's like trying to grow a plant in a dark room. It’s a bit of a struggle, but hey, miracles happen!

  Sell

• CryptoCobra

  Nov 20, 2025

  $CGC Growing cannabis like it's a TikTok trend – always greener on this side, and definitely better for chill vibes!

  Buy

• BullishShade

  Nov 19, 2025

  $CGC Navigating the complexities of the cannabis market requires agility and foresight. This company's strategic partnerships and product diversity could lead to promising developments.

  Buy

• ChartPhantom

  Nov 19, 2025

  $CGC This company's got growth that’s greener than a jealous leprechaun on St. Patrick's Day!

  Buy

• BullishBerserker

  Nov 19, 2025

  $CGC This stock has been swinging wildly, leaving everyone on edge. Can it recover enough to break free from its downward spiral, or is it just another trap waiting to snap shut?

  Sell

• VolatilityViper

  Nov 19, 2025

  $CGC Cannabis? More like a weed in a dying garden.

  Sell

• ProfitFang

  Nov 18, 2025

  $CGC As a key player in the evolving cannabis industry, this corporation continues to innovate and expand its product offerings. With a strong emphasis on research and development, it aims to capture market share in both recreational and medicinal segments.

  Buy

• MarginMeme

  Nov 18, 2025

  $CGC Catchin' vibes but needs a strong push to really shine.

  Sell

• WallStreetRogue

  Nov 18, 2025

  $CGC The cannabis industry is buzzing, but this one seems to be caught in the thicket of regulatory challenges! Can it break free and thrive, or are the warnings too loud to ignore?

  Sell

• MarketWolf

  Nov 17, 2025

  $CGC Facing scrutiny in a turbulent market, this cannabis giant has to pivot fast! Can they bounce back, or are they stuck in a downward spiral?

  Sell

• BullishBard

  Nov 17, 2025

  $CGC This one’s got a high vibe, but let’s hope it doesn’t get too green around the edges! 🍃😆

  Sell

• TradePredator

  Nov 17, 2025

  $CGC This is the stock equivalent of a sinking ship.

  Sell

• GainsJester

  Nov 16, 2025

  $CGC Chillin' in the green scene, they’re rollin' with the big hits!

  Buy

• TickerTyrant

  Nov 15, 2025

  $CGC This stock is more of a joke than a solid investment.

  Sell

• MarketMatrix

  Nov 15, 2025

  $CGC This company is like that friend who always offers you snacks and good vibes – definitely a keeper in any portfolio!

  Buy

• BearishBoi

  Nov 15, 2025

  $CGC Growing plants is fun, but growing profits? Now that's a real green thumb moment! Just don’t forget your watering can!

  Sell

• CodeTrader

  Nov 15, 2025

  $CGC In the cannabis industry, it's always a haze of uncertainty. Will they find their place in a crowded market, or will they fade into obscurity like so many before? It's a tense wait!

  Sell

• DividendHunter

  Nov 14, 2025

  $CGC Cannabis hype might be the only thing growing here.

  Sell

• TradeMatrix

  Nov 14, 2025

  $CGC The pressure mounts as regulatory changes threaten to reshape this company's entire future. Navigating these turbulent times will take sharp strategies and a bit of luck!

  Sell

• GainSurge

  Nov 14, 2025

  $CGC With the cannabis market evolving rapidly, can they stand out in a saturated field, or are they just another name in the crowd? It’s anyone’s guess!

  Sell

• DividendGhost

  Nov 14, 2025

  $CGC This company is like a rollercoaster ride! One moment it’s soaring high, and the next it’s a dizzying drop. Hold on tight—market trends are unpredictable, and the stakes are higher than ever!

  Sell

• AlgoAce

  Nov 14, 2025

  $CGC With a name like that, you can bet they’re either growing big dreams or a lot of greenery!

  Sell

• VolatilityNomad

  Nov 13, 2025

  $CGC You'll need more than luck to make this green.

  Sell

• EarningsEcho

  Nov 13, 2025

  $CGC This stock is like a cactus in the desert: it’s resilient, but you might want to handle it with care!

  Sell

• AlphaDruid

  Nov 13, 2025

  $CGC With regulatory shifts and market volatility, this company is at a crossroads. Can it adapt quickly enough to survive the twists and turns of public perception and policy? Stakes are high!

  Sell

• RiskReaper

  Nov 12, 2025

  $CGC Focused on the rapidly growing cannabis market, this company is positioned as a leading contender. Its investments in product development and market expansion reflect a forward-thinking strategy that aligns with increasing consumer interest in this sector.

  Buy

• StonkDestroyer

  Nov 12, 2025

  $CGC This one's just a bad joke in a market full of punchlines.

  Sell

• FinTechNomad

  Nov 12, 2025

  $CGC In the ever-shifting landscape of cannabis, this company is feeling the heat! Consumers are demanding more while prices are playing hard to get. Can they adapt quickly enough to stay relevant?

  Sell

• ProfitVortex

  Nov 11, 2025

  $CGC This one’s like that friend who always brings snacks to the party - everyone loves it, but will it ever settle down?

  Buy

• TickerTyrant

  Nov 10, 2025

  $CGC Cannabis hype train derailed, still looking for a ticket.

  Sell

• MarketReaper

  Nov 10, 2025

  $CGC With a name like that, you might think they grow things. Spoiler alert: they definitely do, but we’re not talking about flowers.

  Sell

• TheGainReaper

  Nov 9, 2025

  $CGC This cannabis stock is just high on hope.

  Sell

• CapitalCreep

  Nov 8, 2025

  $CGC Still waiting for this growth to kick in.

  Sell

• MarginDagger

  Nov 8, 2025

  $CGC As the cannabis industry evolves, this company remains a relevant player with its adaptive strategies and product diversification. Their forward-thinking approach could provide valuable opportunities in a rapidly changing market.

  Buy

• DiamondHandz

  Nov 8, 2025

  $CGC With all the ups and downs, gotta ask if the green is worth the gamble!

  Sell

• BullBrawler

  Nov 5, 2025

  $CGC I'm not saying it's mooning, but it's definitely packing a suitcase.

  Buy

• YieldMyth

  Nov 4, 2025

  $CGC dripping beastly theta diamond hurts energy on momentum volume spicy fire tape

  Buy

• ProfitGremlin

  Oct 23, 2025

  $CGC not strategy dip this dipping is keeps a hope just

  Sell

• GainVector

  Oct 22, 2025

  $CGC clear spike eyes tape queued my grind watching talking level-to-level today hands hard talking diamond heavy my loud no weak today

  Sell

• BuyLowBro

  Oct 19, 2025

  $CGC gains soon tbh beastly uptrend humming smooth smooth no smooth eyes on tight queued

  Buy

• TradeFrenzy

  Oct 14, 2025

  $CGC This rally just cured my Monday blues. Every breakout feels like a high-five from the trading gods.

  Sell

• RiskRaider

  Oct 12, 2025

  $CGC levels heating smart it rip broken tape eyes here theta mode soon-ish buzzing bleeding today theta risk

  Sell

• FiscalEngine

  Oct 11, 2025

  $CGC I'm emotionally diversified but financially not so much. Trend line straighter.

  Buy

• ShortSurge

  Oct 9, 2025

  $CGC Chart's climbing like it heard good news from the universe.

  Buy

• AlphaVandal

  Sep 24, 2025

  $CGC Confidence level: chart that refuses to dip. Every breakout feels like a high-five from the trading gods.

  Buy

• DividendVortex

  Sep 24, 2025

  $CGC This chart looks like it just had an energy drink. Market mood: confident with a hint of chaos.

  Sell

• TheRiskDealer

  Sep 21, 2025

  $CGC The price action just ghosted resistance again. This chart needs.

  Sell

• OptionRogue

  Sep 16, 2025

  $CGC Volume so low it's whispering sweet nothings. Rally so slow my.

  Sell

• TradeNova

  Sep 7, 2025

  $CGC like is allergic sold smells gets every instantly price to bounce candles regret action green

  Sell

• BearishBoi

  Sep 6, 2025

  $CGC wild vol on soon feels watching sentiment soon dripping vibes maybe volume alpha heating tight feels buzzing spike it range on hard range heavy clear

  Buy

• BullishSniper

  Sep 5, 2025

  $CGC That breakout had better timing than my morning coffee. Price action so smooth it deserves.

  Buy

• AlphaStriker

  Aug 30, 2025

  $CGC hazard deserve pay investors

  Sell

• FOMOKing

  Aug 29, 2025

  $CGC Volume so low it's whispering sweet nothings. Riding this wave with tears of joy and a side of.

  Sell

• LiquidityLord

  Aug 26, 2025

  $CGC me stock this bills therapy owes

  Buy

• HedgeKnight

  Aug 21, 2025

  $CGC Bulls and bears are just trading insults now. Chart's doing interpretive.

  Sell

• CapitalCarnage

  Jul 14, 2025

  $CGC mode cat imo mode ugly steady whoa imo soon tape bear doom stops

  Sell

• OptionCipher

  Jun 23, 2025

  $CGC imo whispers imo soon charts heater move noise hard alpha hurts mooning tax eyes loud earnings

  Buy

• TradeBlitz

  May 23, 2025

  $CGC hurts now level-to-level crushing on gap sentiment staying mooning whispers imo gains queued heavy ath

  Buy

• DiamondHandz

  May 19, 2025

  $CGC whispers candle risk rough rip it hedges session weak levels broken patience charts loud

  Sell

• RiskReaper

  May 18, 2025

  $CGC choppy wall mess nasty candle clean fast dumping patience sentiment dive nimble earnings talking

  Sell

• RocketDividend

  May 11, 2025

  $CGC tbh whoa soon grind tape crushing rocket charts spicy spike tight heavy eyes bull macro diamond staying watching dripping today

  Buy

• TradeGoblin

  Mar 25, 2025

  $CGC breakout soon tape vol move risk buzzing hurts no mooning pumping

  Buy

• MarketReaper

  Mar 7, 2025

  $CGC liquidity my look rip wick hands dumping doom hard humming today

  Sell

• ChartNomad

  Nov 16, 2024

  $CGC rough volume level-to-level choppy nimble soon bagholder session stops trend here dumping

  Sell

• YieldMyth

  Aug 30, 2024

  $CGC supply mess lower today rip supply heavy smart levels trend diamond volume ugly

  Sell

• CapitalCarnage

  Aug 17, 2024

  $CGC clean today choppy range cliff dead trap grind tape feels weak dive

  Sell

• MoneyMage

  Jul 28, 2024

  $CGC lows broken mode nimble hurts clean fading look watching supply trigger here frankly liquidity level-to-level soon loud out

  Sell

• CapitalFrame

  Jun 4, 2024

  $CGC vibes heating fast diamond tape hurts frankly earnings feels macro weak dive whispers humming flows mode watching noise doom

  Sell

• TickerPhantom

  Jan 12, 2024

  $CGC stops cliff ugly on dumping vol levels out fading risk

  Sell

• BearBreaker

  Dec 19, 2023

  $CGC tape headfake loud bear eyes nasty my wick dead clear

  Sell